Thanks, we're all hoping for the best of luck with kevetrin as well. And in the lab results kevetrin is that apoptosis drug, it is a first of its kind drug and why there is an enormous amount of potential. I hope all the best for your drug with its anti-inflammatory progress as well!
Dozens of apoptosis drugs are successful in reducing tumor growth in preclinical studies, so far all have been either highly cytotoxic or mutagenetic at therapeutic values, when not both. That is what separates Kevetrin from all previous attempts at this approach. Kevetrin has a low toxicity profile and is non-mutagenetic.